C Xie, R Quan, F Hong, K Zou, W Yan, Y Fu - BMC gastroenterology, 2019 - Springer
Background Mesalamine is a first-line drug in the treatment of inflammatory bowel diseases,
while its intolerance occasionally occurs in clinical practice. Most of adverse reactions are …